title: Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years.
abstract: During the past two decades the first sequencing of the human genome was performed showing its high degree of inter-individual differentiation, as a result of large international research projects (Human Genome Project, the 1000 Genomes Project International HapMap Project, and Programs for Genomic Applications NHLBI-PGA). This period was also a time of intensive development of molecular biology techniques and enormous knowledge growth in the biology of cancer. For clinical use in the treatment of patients with colorectal cancer (CRC), in addition to fluoropyrimidines, another two new cytostatic drugs were allowed: irinotecan and oxaliplatin. Intensive research into new treatment regimens and a new generation of drugs used in targeted therapy has also been conducted. The last 20 years was a time of numerous in vitro and in vivo studies on the molecular basis of drug resistance. One of the most important factors limiting the effectiveness of chemotherapy is the primary and secondary resistance of cancer cells. Understanding the genetic factors and mechanisms that contribute to the lack of or low sensitivity of tumour tissue to cytostatics is a key element in the currently developing trend of personalized medicine. Scientists hope to increase the percentage of positive treatment response in CRC patients due to practical applications of pharmacogenetics/pharmacogenomics. Over the past 20 years the clinical usability of different predictive markers has been tested among which only a few have been confirmed to have high application potential. This review is a synthetic presentation of drug resistance in the context of CRC patient chemotherapy. The multifactorial nature and volume of the issues involved do not allow the author to present a comprehensive study on this subject in one review.
authors.affiliation: Mariusz Panczyk, Laboratory of Molecular Diagnostics and Pharmacogenomics, Department of Pharmaceutical Biochemistry, Medical University of Lodz, 90-151 Lodz, Poland.
authors.forename: Mariusz
authors.initials: M
authors.lastname: Panczyk
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001711:Biotransformation / Q000235:genetics; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D019008:Drug Resistance, Neoplasm; D005820:Genetic Testing; D006801:Humans; D026901:Membrane Transport Proteins / Q000235:genetics / Q000378:metabolism; D018579:Patient Selection; D010597:Pharmacogenetics; D057285:Precision Medicine; D011237:Predictive Value of Tests; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D026901:Membrane Transport Proteins
keywords: Chemoresistance; Colorectal cancer; Drug resistance; Individualized medicine; Pharmacogenetics; Pharmacogenomics
references.citation: Oncol Rep. 2005 Sep;14(3):657-62
references.pmid: 16077970
references.citation: Cancer Chemother Pharmacol. 2012 Jun;69(6):1591-9
references.pmid: 22535333
references.citation: Pharmacogenet Genomics. 2005 May;15(5):295-301
references.pmid: 15864130
references.citation: Protein Pept Lett. 2009;16(10):1207-14
references.pmid: 19508181
references.citation: DNA Repair (Amst). 2003 Sep 18;2(9):947-54
references.pmid: 12967652
references.citation: Int J Clin Oncol. 2003 Apr;8(2):72-8
references.pmid: 12720098
references.citation: Pharmacogenomics. 2009 Aug;10(8):1285-94
references.pmid: 19663673
references.citation: Clin Cancer Res. 2007 Oct 15;13(20):6093-8
references.pmid: 17947473
references.citation: Int J Clin Oncol. 2004 Oct;9(5):388-92
references.pmid: 15549590
references.citation: Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8699-705
references.pmid: 16361556
references.citation: Br J Cancer. 1998 Jun;77(12):2171-6
references.pmid: 9649129
references.citation: Recent Results Cancer Res. 2007;176:81-8
references.pmid: 17607918
references.citation: Ther Drug Monit. 2006 Oct;28(5):678-85
references.pmid: 17038885
references.citation: Carcinogenesis. 2013 Apr;34(4):725-38
references.pmid: 23455378
references.citation: Pharmacogenetics. 2004 May;14(5):319-27
references.pmid: 15115918
references.citation: Anticancer Drugs. 1995 Jun;6(3):413-8
references.pmid: 7670139
references.citation: Cancer Chemother Pharmacol. 2008 Aug;62(3):529-37
references.pmid: 17992531
references.citation: Pharmacogenomics J. 2001;1(1):65-70
references.pmid: 11913730
references.citation: Clin Colorectal Cancer. 2004 Sep;4(3):181-9
references.pmid: 15377401
references.citation: Biochim Biophys Acta. 2013 Jan;1835(1):11-27
references.pmid: 23006513
references.citation: Cancer Epidemiol Biomarkers Prev. 2000 Dec;9(12):1381-5
references.pmid: 11142426
references.citation: Ther Drug Monit. 2007 Jun;29(3):265-70
references.pmid: 17529881
references.citation: Scand J Gastroenterol. 2007 Apr;42(4):477-84
references.pmid: 17454858
references.citation: Curr Opin Pharmacol. 2007 Aug;7(4):367-74
references.pmid: 17681492
references.citation: Arch Pharm Res. 2006 Dec;29(12):1067-73
references.pmid: 17225452
references.citation: Biomed Pharmacother. 1989;43(4):251-60
references.pmid: 2790145
references.citation: Mol Cell Biol. 1994 Jan;14(1):207-13
references.pmid: 8264588
references.citation: Asian Pac J Cancer Prev. 2013;14(5):3085-91
references.pmid: 23803084
references.citation: Arh Hig Rada Toksikol. 2009 Jun;60(2):217-42
references.pmid: 19581216
references.citation: J Clin Oncol. 2004 Feb 1;22(3):529-36
references.pmid: 14752076
references.citation: Cancer Res. 1999 Sep 15;59(18):4559-63
references.pmid: 10493507
references.citation: Hum Genet. 1999 Jan;104(1):1-9
references.pmid: 10071185
references.citation: Cancer Res. 2006 Sep 1;66(17):8847-57
references.pmid: 16951202
references.citation: BMC Cancer. 2007 Jul 05;7:123
references.pmid: 17615053
references.citation: J Biol Chem. 2004 Sep 3;279(36):37343-8
references.pmid: 15218034
references.citation: Br J Cancer. 2010 Aug 10;103(4):581-9
references.pmid: 20628391
references.citation: Int J Cancer. 2008 Nov 15;123(10):2384-9
references.pmid: 18729195
references.citation: Hum Genet. 2010 Nov;128(5):529-38
references.pmid: 20803296
references.citation: Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11440-5
references.pmid: 10500195
references.citation: J Natl Cancer Inst. 2004 Jan 21;96(2):134-44
references.pmid: 14734703
references.citation: Cancer Res. 2001 Dec 15;61(24):8654-8
references.pmid: 11751380
references.citation: J Biol Chem. 2004 Feb 13;279(7):5244-8
references.pmid: 14699148
references.citation: Biochem Pharmacol. 2009 Dec 1;78(11):1366-73
references.pmid: 19622348
references.citation: Drug Metab Dispos. 2008 Apr;36(4):780-95
references.pmid: 18180275
references.citation: Mol Pharmacol. 1985 Nov;28(5):461-7
references.pmid: 2932632
references.citation: Mol Cancer Ther. 2009 Oct;8(10):2959-68
references.pmid: 19825807
references.citation: Eur J Cancer. 2008 Feb;44(3):400-7
references.pmid: 18068349
references.citation: J Hum Genet. 2001;46(11):656-63
references.pmid: 11721885
references.citation: Neoplasia. 2009 Dec;11(12):1359-70
references.pmid: 20019844
references.citation: Br J Clin Pharmacol. 2005 Apr;59(4):415-24
references.pmid: 15801936
references.citation: Clin Chim Acta. 1984 Jul 31;140(3):247-56
references.pmid: 6467612
references.citation: J Clin Oncol. 2008 May 1;26(13):2131-8
references.pmid: 18299612
references.citation: J Natl Cancer Inst. 2002 Jun 19;94(12):936-42
references.pmid: 12072547
references.citation: Toxicol In Vitro. 2006 Mar;20(2):163-75
references.pmid: 16271446
references.citation: Cancer Res. 1995 Apr 15;55(8):1687-90
references.pmid: 7536129
references.citation: Cell. 1997 Feb 7;88(3):323-31
references.pmid: 9039259
references.citation: J Clin Oncol. 2005 Jan 20;23(3):609-18
references.pmid: 15659508
references.citation: J Clin Oncol. 1997 Oct;15(10):3223-9
references.pmid: 9336359
references.citation: Pharmacogenet Genomics. 2007 Jul;17(7):497-504
references.pmid: 17558305
references.citation: Pharmacogenomics J. 2013 Oct;13(5):403-9
references.pmid: 22868256
references.citation: Ann Oncol. 1998 Oct;9(10):1053-71
references.pmid: 9834817
references.citation: Mol Pharmacol. 2006 Oct;70(4):1390-4
references.pmid: 16847145
references.citation: Int J Oncol. 2001 Aug;19(2):383-6
references.pmid: 11445856
references.citation: Clin Cancer Res. 2011 Jun 1;17(11):3822-9
references.pmid: 21471424
references.citation: Int J Cancer. 2012 Dec 15;131(12):2920-8
references.pmid: 22473764
references.citation: Int J Colorectal Dis. 2010 Oct;25(10):1167-76
references.pmid: 20533057
references.citation: Pharmacogenomics. 2011 Mar;12(3):433-42
references.pmid: 21449681
references.citation: J Natl Cancer Inst. 1998 Aug 19;90(16):1225-9
references.pmid: 9719084
references.citation: Anticancer Res. 1995 Mar-Apr;15(2):405-9
references.pmid: 7763013
references.citation: PLoS One. 2008;3(12):e4003
references.pmid: 19104657
references.citation: Br J Cancer. 2009 May 19;100(10):1549-57
references.pmid: 19384296
references.citation: Cancer Res. 2003 Jun 1;63(11):2898-904
references.pmid: 12782596
references.citation: Eur J Hum Genet. 2007 Oct;15(10):1049-53
references.pmid: 17593927
references.citation: Cancer Res. 1997 May 15;57(10):1841-5
references.pmid: 9157971
references.citation: Cancer Treat Rev. 2005 Dec;31(8):648-52
references.pmid: 16289340
references.citation: Anticancer Res. 2007 Mar-Apr;27(2):851-6
references.pmid: 17465211
references.citation: Anticancer Res. 2001 Jul-Aug;21(4B):3075-9
references.pmid: 11712813
references.citation: J Surg Oncol. 2006 Jul 1;94(1):45-50
references.pmid: 16788943
references.citation: Int J Cancer. 2004 May 10;109(6):848-54
references.pmid: 15027118
references.citation: Cancer Chemother Pharmacol. 2009 Jun;64(1):133-42
references.pmid: 18998134
references.citation: APMIS. 2005 Sep;113(9):600-2
references.pmid: 16218935
references.citation: J Clin Oncol. 2007 Apr 1;25(10):1247-54
references.pmid: 17401013
references.citation: Clin Cancer Res. 2003 Aug 15;9(9):3246-53
references.pmid: 12960109
references.citation: J Clin Pharm Ther. 2008 Jun;33(3):307-14
references.pmid: 18452418
references.citation: Clin Cancer Res. 2000 Dec;6(12):4705-12
references.pmid: 11156223
references.citation: Mol Pharmacol. 2006 Jul;70(1):287-96
references.pmid: 16608919
references.citation: J Clin Oncol. 2004 May 1;22(9):1572-82
references.pmid: 15117979
references.citation: Cancer Res. 1996 Nov 1;56(21):4881-6
references.pmid: 8895738
references.citation: Biochem Pharmacol. 1996 Dec 24;52(12):1855-65
references.pmid: 8951344
references.citation: Biochem J. 2002 May 15;364(Pt 1):157-63
references.pmid: 11988088
references.citation: Br J Cancer. 2003 Oct 20;89(8):1486-92
references.pmid: 14562021
references.citation: Hum Mutat. 2004 Jan;23(1):100
references.pmid: 14695543
references.citation: Anticancer Drugs. 2009 Apr;20(4):217-29
references.pmid: 19247178
references.citation: Lung Cancer. 2002 Mar;35(3):299-304
references.pmid: 11844605
references.citation: Curr Med Chem. 2008;15(20):1981-2039
references.pmid: 18691054
references.citation: Hum Mutat. 2003 Dec;22(6):498
references.pmid: 14635116
references.citation: Drug Metab Rev. 2008;40(2):317-54
references.pmid: 18464048
references.citation: World J Gastrointest Surg. 2010 Jan 27;2(1):14-21
references.pmid: 21160829
references.citation: Lancet. 1995 Apr 15;345(8955):958-9
references.pmid: 7715297
references.citation: Pharmacogenet Genomics. 2005 Oct;15(10):723-30
references.pmid: 16141798
references.citation: Clin Cancer Res. 2011 May 15;17(10):3455-68
references.pmid: 21498394
references.citation: Oncology. 2007;72(5-6):364-70
references.pmid: 18204222
references.citation: Pharmacogenetics. 2004 May;14(5):329-32
references.pmid: 15115919
references.citation: Cancer Res. 2001 Jul 1;61(13):5193-201
references.pmid: 11431359
references.citation: Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10296-301
references.pmid: 10468602
references.citation: Br J Cancer. 2008 Oct 21;99(8):1239-45
references.pmid: 18797458
references.citation: Pharmacogenomics. 2004 Apr;5(3):243-72
references.pmid: 15102541
references.citation: Drug Metab Dispos. 2005 Oct;33(10):1482-7
references.pmid: 16033949
references.citation: Clin Cancer Res. 2002 Mar;8(3):768-74
references.pmid: 11895907
references.citation: Gan To Kagaku Ryoho. 2006 Nov;33(11):1603-9
references.pmid: 17108726
references.citation: Int J Cancer. 2009 Mar 1;124(5):1220-6
references.pmid: 19051292
references.citation: BMC Cancer. 2008 Dec 23;8:386
references.pmid: 19105824
references.citation: J Clin Oncol. 2009 May 20;27(15):2530-5
references.pmid: 19349543
references.citation: Pharmacogenomics. 2007 Dec;8(12):1693-703
references.pmid: 18085999
references.citation: Br J Cancer. 2008 Oct 21;99(8):1316-21
references.pmid: 18797455
references.citation: Cancer Chemother Pharmacol. 2008 Mar;61(3):481-8
references.pmid: 17483951
references.citation: Lung Cancer. 2008 Jan;59(1):69-75
references.pmid: 17766002
references.citation: Cancer Res. 2000 Nov 1;60(21):6039-44
references.pmid: 11085525
references.citation: J Clin Oncol. 2001 Dec 1;19(23):4298-304
references.pmid: 11731512
references.citation: Clin Cancer Res. 2000 May;6(5):2012-20
references.pmid: 10815927
references.citation: Clin Cancer Res. 2008 Feb 1;14(3):817-25
references.pmid: 18245544
references.citation: Clin Adv Hematol Oncol. 2003 Mar;1(3):162-6
references.pmid: 16224397
references.citation: Curr Cancer Drug Targets. 2012 Oct;12(8):962-86
references.pmid: 22794121
references.citation: Gastroenterology. 1999 Jul;117(1):123-31
references.pmid: 10381918
references.citation: Int J Clin Oncol. 2002 Dec;7(6):335-42
references.pmid: 12494248
references.citation: Int J Cancer. 2004 Mar 20;109(2):238-46
references.pmid: 14750175
references.citation: Br J Cancer. 2008 Oct 7;99(7):1050-5
references.pmid: 18797464
references.citation: Biochem Biophys Res Commun. 2008 May 9;369(3):939-42
references.pmid: 18328811
references.citation: Cancer Chemother Pharmacol. 2000;45(4):291-7
references.pmid: 10755317
references.citation: J Clin Oncol. 2004 Jan 15;22(2):229-37
references.pmid: 14657227
references.citation: Am J Hum Genet. 1997 Mar;60(3):525-39
references.pmid: 9042911
references.citation: Biochem Pharmacol. 1990 Nov 15;40(10):2353-62
references.pmid: 2244936
references.citation: Gan To Kagaku Ryoho. 2005 Nov;32(12):1929-34
references.pmid: 16282729
references.citation: Eur J Cancer. 1995 Jul-Aug;31A(7-8):1306-10
references.pmid: 7577041
references.citation: Int J Colorectal Dis. 2006 Apr;21(3):238-47
references.pmid: 16132996
references.citation: Int J Oncol. 2006 Feb;28(2):527-33
references.pmid: 16391809
references.citation: Clin Cancer Res. 1998 May;4(5):1243-50
references.pmid: 9607583
references.citation: J Clin Oncol. 2009 Jun 1;27(16):2604-14
references.pmid: 19349540
references.citation: J Clin Oncol. 2004 Sep 15;22(18):3766-75
references.pmid: 15365073
references.citation: Eur J Cancer. 1998 Sep;34(10):1535-42
references.pmid: 9893624
references.citation: Carcinogenesis. 2004 Sep;25(9):1695-700
references.pmid: 15090466
references.citation: Br J Cancer. 1999 Mar;79(7-8):1104-10
references.pmid: 10098743
references.citation: J Clin Oncol. 2008 Jun 1;26(16):2690-8
references.pmid: 18509181
references.citation: Int J Biochem Cell Biol. 2007;39(3):565-75
references.pmid: 17098463
references.citation: Biochem Biophys Res Commun. 1974 Apr 8;57(3):689-95
references.pmid: 4275130
references.citation: Int J Cancer. 2004 Dec 10;112(5):733-7
references.pmid: 15386371
references.citation: Pharmacogenetics. 2004 Dec;14(12):785-92
references.pmid: 15608557
references.citation: Chem Rev. 2007 May;107(5):1387-407
references.pmid: 17455916
references.citation: Br J Clin Pharmacol. 2010 Jan;69(1):58-66
references.pmid: 20078613
references.citation: Pharmacogenomics. 2012 Jun;13(8):889-99
references.pmid: 22676194
references.citation: Cancer Chemother Pharmacol. 2001 Nov;48(5):398-406
references.pmid: 11761458
references.citation: Biochem Pharmacol. 2010 Apr 15;79(8):1108-17
references.pmid: 20005867
references.citation: Eur J Cancer. 1996 Jun;32A(7):1227-32
references.pmid: 8758258
references.citation: Pharmacogenomics J. 2011 Feb;11(1):61-71
references.pmid: 20177420
references.citation: J Biol Chem. 2004 Dec 31;279(53):55618-25
references.pmid: 15494395
references.citation: Clin Cancer Res. 2005 Feb 1;11(3):1226-36
references.pmid: 15709193
references.citation: Pharmacogenomics. 2009 Jun;10(6):931-44
references.pmid: 19530960
references.citation: J Clin Oncol. 2007 Aug 20;25(24):3726-31
references.pmid: 17704422
references.citation: Oncogene. 2003 Oct 20;22(47):7369-75
references.pmid: 14576844
references.citation: Clin Cancer Res. 2003 Oct 1;9(12):4363-7
references.pmid: 14555507
references.citation: Mol Pharmacol. 2009 Feb;75(2):324-30
references.pmid: 18996970
references.citation: Sci Eng Ethics. 2004 Jan;10(1):73-9
references.pmid: 14986774
references.citation: Clin Cancer Res. 2006 Dec 1;12(23):7149-58
references.pmid: 17145840
references.citation: Clin Cancer Res. 2003 Aug 1;9(8):3052-7
references.pmid: 12912956
references.citation: Clin Chim Acta. 2012 Dec 24;414:109-11
references.pmid: 22935545
references.citation: Cell Struct Funct. 1995 Jun;20(3):191-7
references.pmid: 7586009
references.citation: Cancer Lett. 2007 May 8;249(2):271-82
references.pmid: 17064846
references.citation: Oncogene. 2004 Mar 4;23(9):1737-44
references.pmid: 15001986
references.citation: Colorectal Dis. 2013 Jan;15(1):12-8
references.pmid: 23279665
references.citation: Clin Cancer Res. 2005 Sep 1;11(17):6212-7
references.pmid: 16144923
references.citation: Cancer Treat Rev. 2013 Oct;39(6):592-601
references.pmid: 23375249
references.citation: Eur J Clin Pharmacol. 2013 May;69 Suppl 1:17-23
references.pmid: 23640184
references.citation: Int J Cancer. 2006 Jul 15;119(2):406-13
references.pmid: 16477629
references.citation: J Clin Oncol. 2005 Mar 1;23(7):1365-9
references.pmid: 15735113
references.citation: Cancer Chemother Pharmacol. 2013 Feb;71(2):361-70
references.pmid: 23139054
references.citation: J R Coll Physicians Edinb. 2011 Dec;41(4):323
references.pmid: 22184570
references.citation: Cancer Sci. 2010 Feb;101(2):530-5
references.pmid: 19922504
references.citation: J Clin Oncol. 1988 Oct;6(10):1653-64
references.pmid: 3049954
references.citation: Cancer. 2011 Jul 15;117(14):3156-62
references.pmid: 21287524
references.citation: Cancer Res. 1999 Aug 15;59(16):3968-71
references.pmid: 10463593
references.citation: Crit Rev Oncol Hematol. 2005 Jan;53(1):3-11
references.pmid: 15607931
references.citation: Cancer Res. 1999 Jun 1;59(11):2557-61
references.pmid: 10363972
references.citation: Onkologie. 2007 Jun;30(6):295-300
references.pmid: 17551252
references.citation: Clin Cancer Res. 2004 Sep 1;10(17):5889-94
references.pmid: 15355921
references.citation: J Clin Invest. 1996 Aug 1;98(3):610-5
references.pmid: 8698850
references.citation: Mutat Res. 1997 Sep;382(1-2):13-20
references.pmid: 9360634
references.citation: Cancer Chemother Pharmacol. 2009 May;63(6):1165-9
references.pmid: 18998132
references.citation: Drug Resist Updat. 2004 Aug-Oct;7(4-5):227-32
references.pmid: 15533760
references.citation: Int J Colorectal Dis. 2002 Jan;17(1):46-9
references.pmid: 12018454
references.citation: Cancer Res. 1997 May 1;57(9):1660-3
references.pmid: 9135003
references.citation: Cancer Chemother Pharmacol. 2010 Jan;65(2):403-6
references.pmid: 19795123
references.citation: Br J Cancer. 1999 Dec;81(8):1285-93
references.pmid: 10604724
references.citation: Int J Colorectal Dis. 2009 Aug;24(8):895-905
references.pmid: 19415305
references.citation: Tumour Biol. 2013 Jun;34(3):1949-57
references.pmid: 23504525
references.citation: Br J Cancer. 2000 Feb;82(3):560-7
references.pmid: 10682666
references.citation: Cancer Res. 2004 Jan 1;64(1):356-62
references.pmid: 14729645
references.citation: Clin Cancer Res. 1997 Aug;3(8):1261-6
references.pmid: 9815808
references.citation: Steroids. 2002 Jun;67(7):627-36
references.pmid: 11996936
references.citation: Pharmacogenet Genomics. 2007 Jan;17(1):1-10
references.pmid: 17264798
references.citation: Cancer Res. 2001 May 1;61(9):3535-40
references.pmid: 11325813
references.citation: Mol Pharmacol. 2010 Jun;77(6):887-94
references.pmid: 20159940
references.citation: Autophagy. 2012 Jul 1;8(7):1098-112
references.pmid: 22647487
references.citation: Clin Biochem. 2013 Apr;46(6):466-79
references.pmid: 23159294
references.citation: Anticancer Drugs. 2010 Mar;21(3):313-9
references.pmid: 20016369
references.citation: J Clin Oncol. 1994 Nov;12(11):2248-53
references.pmid: 7964939
references.citation: Clin Cancer Res. 2008 Mar 15;14(6):1788-96
references.pmid: 18347181
references.citation: Pharmacogenomics. 2011 Mar;12(3):341-50
references.pmid: 21449674
references.citation: Br J Cancer. 2009 Mar 24;100(6):1017
references.pmid: 19293816
references.citation: Cancer Chemother Pharmacol. 2011 Jun;67(6):1323-31
references.pmid: 20734048
references.citation: Pharmacogenet Genomics. 2006 Sep;16(9):683-91
references.pmid: 16906022
references.citation: Biochem Pharmacol. 2007 Jun 30;74(1):41-53
references.pmid: 17481587
references.citation: Cancer Chemother Pharmacol. 2002 Apr;49(4):329-35
references.pmid: 11914913
references.citation: Br J Cancer. 1993 Jun;67(6):1171-6
references.pmid: 8512802
references.citation: J Clin Oncol. 2006 Sep 10;24(26):4225-7
references.pmid: 16895999
references.citation: Am J Clin Oncol. 2009 Feb;32(1):38-43
references.pmid: 19194123
references.citation: Chin J Cancer. 2012 Feb;31(2):58-72
references.pmid: 22098952
references.citation: J Clin Oncol. 2009 Jun 10;27(17):2863-73
references.pmid: 19332728
references.citation: J Clin Oncol. 2009 Nov 20;27(33):5519-28
references.pmid: 19858398
references.citation: Br J Cancer. 1990 Jul;62(1):72-7
references.pmid: 2390486
references.citation: Pharmacogenetics. 2000 Apr;10(3):217-23
references.pmid: 10803677
references.citation: Oncol Rep. 2008 Mar;19(3):729-35
references.pmid: 18288408
references.citation: Mol Cancer Ther. 2009 May;8(5):1000-7
references.pmid: 19383851
references.citation: Cancer Biol Ther. 2005 Jun;4(6):650-8
references.pmid: 15908806
references.citation: Pediatr Res. 1994 Jun;35(6):629-32
references.pmid: 7936809
references.citation: Eur J Cancer. 2008 Jun;44(9):1229-37
references.pmid: 18448328
references.citation: Ann Oncol. 2008 May;19(5):915-9
references.pmid: 18245778
references.citation: J Hum Genet. 2006;51(3):155-160
references.pmid: 16424979
references.citation: Biochem Biophys Res Commun. 2002 Mar 29;292(2):492-7
references.pmid: 11906189
references.citation: Clin Cancer Res. 2005 Aug 15;11(16):5886-92
references.pmid: 16115930
references.citation: Clin Cancer Res. 2001 May;7(5):1149-53
references.pmid: 11350878
references.citation: Drug Resist Updat. 1999 Oct;2(5):307-318
references.pmid: 11504505
references.citation: Int J Oncol. 2000 Mar;16(3):555-60
references.pmid: 10675489
references.citation: Clin Cancer Res. 1999 Feb;5(2):325-8
references.pmid: 10037181
references.citation: Anticancer Res. 2011 Jan;31(1):359-66
references.pmid: 21273624
references.citation: Eur J Cancer. 1996;32A Suppl 3:S13-7
references.pmid: 8943660
references.citation: Int J Oncol. 2012 Jan;40(1):217-26
references.pmid: 21901246
references.citation: Drug Metab Dispos. 2007 Dec;35(12):2149-53
references.pmid: 17761781
references.citation: Biochem Mol Biol Int. 1998 Sep;46(1):21-6
references.pmid: 9784835
references.citation: Lung Cancer. 2009 May;64(2):131-9
references.pmid: 18804893
references.citation: J Clin Oncol. 2002 Jun 15;20(12):2832-43
references.pmid: 12065560
references.citation: J Biol Chem. 2004 Aug 6;279(32):33035-8
references.pmid: 15096496
references.citation: Int J Colorectal Dis. 2004 Nov;19(6):533-7
references.pmid: 15175889
references.citation: Oncol Rep. 2002 Mar-Apr;9(2):231-4
references.pmid: 11836585
references.citation: BMC Cancer. 2008 Jul 02;8:188
references.pmid: 18597678
references.citation: Int J Cancer. 2008 Oct 15;123(8):1941-9
references.pmid: 18661526
references.citation: Front Genet. 2012 Nov 02;3:229
references.pmid: 23130019
references.citation: Cancer Res. 2000 Oct 15;60(20):5621-4
references.pmid: 11059750
references.citation: Int J Cancer. 2012 Jul 15;131(2):438-45
references.pmid: 21898389
references.citation: Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15095-100
references.pmid: 14645705
references.citation: Curr Cancer Drug Targets. 2003 Feb;3(1):21-9
references.pmid: 12570658
references.citation: Biochem Biophys Res Commun. 1993 Dec 30;197(3):1239-44
references.pmid: 8280139
references.citation: Cancer Sci. 2007 Feb;98(2):231-9
references.pmid: 17297656
references.citation: Cancer Chemother Pharmacol. 2013 Jun;71(6):1463-72
references.pmid: 23543295
references.citation: Eur J Cancer. 2009 Mar;45(4):572-8
references.pmid: 19084393
references.citation: Cancer Res. 2000 Dec 15;60(24):6921-6
references.pmid: 11156391
references.citation: Clin Cancer Res. 2000 Apr;6(4):1322-7
references.pmid: 10778957
references.citation: Nucleic Acids Res. 2003 Oct 1;31(19):5526-33
references.pmid: 14500814
references.citation: Br J Pharmacol. 2010 Feb;159(4):898-908
references.pmid: 20067471
references.citation: Cancer Sci. 2009 Feb;100(2):278-83
references.pmid: 19068092
references.citation: Drug Metab Dispos. 2007 Oct;35(10):1865-72
references.pmid: 17640957
references.citation: Surgery. 2007 Mar;141(3):346-53
references.pmid: 17349846
references.citation: Eur J Cancer. 2009 Jul;45(11):1999-2006
references.pmid: 19457654
references.citation: Eur J Cancer. 2011 Aug;47(12):1826-36
references.pmid: 21665462
references.citation: Genomics. 2004 Oct;84(4):661-8
references.pmid: 15475243
references.citation: BMC Cancer. 2008 May 27;8:148
references.pmid: 18505590
references.citation: Clin Cancer Res. 2011 Mar 15;17(6):1632-40
references.pmid: 21278243
references.citation: Anticancer Res. 2004 Jan-Feb;24(1):273-9
references.pmid: 15015608
references.citation: Pharmacogenomics. 2010 Mar;11(3):391-406
references.pmid: 20235794
references.citation: Oncogene. 2002 Jul 11;21(30):4595-600
references.pmid: 12096336
references.citation: Science. 1988 Sep 30;241(4874):1813-5
references.pmid: 3175622
references.citation: Genome Res. 2010 Aug;20(8):1020-36
references.pmid: 20538623
references.citation: Curr Drug Metab. 2001 Dec;2(4):367-77
references.pmid: 11766988
references.citation: Pharmacogenet Genomics. 2008 Jan;18(1):25-35
references.pmid: 18216719
references.citation: Anticancer Res. 2010 Feb;30(2):645-51
references.pmid: 20332484
references.citation: Int J Clin Exp Med. 2012;5(2):186-94
references.pmid: 22567180
references.citation: Mol Pharmacol. 2004 Jul;66(1):25-32
references.pmid: 15213293
references.citation: Mol Cancer Ther. 2006 Nov;5(11):2895-904
references.pmid: 17121937
references.citation: Pharmacogenomics. 2011 Feb;12(2):251-65
references.pmid: 21332317
references.citation: Ann Oncol. 2002 Dec;13(12):1882-92
references.pmid: 12453856
references.citation: Pharmacogenomics. 2013 Jun;14(8):897-911
references.pmid: 23746184
references.citation: Cancer. 2006 Mar 1;106(5):1007-16
references.pmid: 16456808
references.citation: Clin Cancer Res. 2010 Sep 15;16(18):4616-24
references.pmid: 20679350
references.citation: J Intern Med. 2013 Jul;274(1):1-24
references.pmid: 23527888
references.citation: Mol Pharmacol. 1999 May;55(5):921-8
references.pmid: 10220571
references.citation: J Exp Clin Cancer Res. 2008 Oct 20;27:54
references.pmid: 18937829
references.citation: Clin Cancer Res. 2000 Dec;6(12):4797-802
references.pmid: 11156237
references.citation: Eur J Cancer. 2010 Jul;46(10):1856-65
references.pmid: 20335017
references.citation: Br J Cancer. 2009 Jul 21;101(2):357-62
references.pmid: 19536092
references.citation: J Natl Cancer Inst. 2004 Nov 3;96(21):1585-92
references.pmid: 15523087
references.citation: Carcinogenesis. 2000 May;21(5):965-71
references.pmid: 10783319
references.citation: Cancer. 2007 Jul 1;110(1):138-47
references.pmid: 17534875
references.citation: Cancer. 2000 Jul 15;89(2):288-96
references.pmid: 10918158
references.citation: Carcinogenesis. 2002 Feb;23(2):295-9
references.pmid: 11872635
references.citation: Clin Pharmacol Ther. 1999 May;65(5):576-82
references.pmid: 10340924
references.citation: Ther Drug Monit. 2007 Oct;29(5):666-8
references.pmid: 17898662
references.citation: Chin Med J (Engl). 2012 Mar;125(5):741-6
references.pmid: 22490566
references.citation: Br J Cancer. 2013 Jun 25;108(12):2505-15
references.pmid: 23736036
references.citation: Ann Oncol. 1998 Aug;9(8):845-7
references.pmid: 9789606
references.citation: Ann Oncol. 2004 Jan;15(1):55-8
references.pmid: 14679120
references.citation: Biochem Biophys Res Commun. 2007 Apr 6;355(2):477-82
references.pmid: 17303082
references.citation: Semin Oncol. 1998 Apr;25(2 Suppl 5):4-12
references.pmid: 9609103
references.citation: Mol Pharmacol. 2002 Sep;62(3):608-17
references.pmid: 12181437
references.citation: Int J Cancer. 2004 Aug 20;111(2):252-8
references.pmid: 15197779
references.citation: Ann Oncol. 2011 Feb;22(2):355-61
references.pmid: 20647221
references.citation: Cancer Res. 2011 Mar 1;71(5):1858-70
references.pmid: 21363922
references.citation: Int J Cancer. 2002 Sep 1;101(1):23-31
references.pmid: 12209584
references.citation: Gynecol Oncol. 2012 Mar;124(3):575-81
references.pmid: 22112610
references.citation: J Clin Oncol. 2004 Jul 1;22(13):2594-601
references.pmid: 15173214
references.citation: Pharmacogenomics J. 2008 Aug;8(4):278-88
references.pmid: 17549067
references.citation: PLoS One. 2012;7(3):e32784
references.pmid: 22396794
references.citation: J Clin Oncol. 2006 May 20;24(15):2237-44
references.pmid: 16636344
references.citation: J Clin Oncol. 2006 Apr 20;24(12):1883-91
references.pmid: 16622263
references.citation: Int J Biol Markers. 2013 Jun 28;28(2):182-6
references.pmid: 23558935
references.citation: Cancer Res. 1979 Jul;39(7 Pt 1):2406-13
references.pmid: 156065
references.citation: Cancer Treat Rev. 2005 Apr;31(2):90-105
references.pmid: 15847979
references.citation: Ann Oncol. 2009 Jun;20(6):1048-56
references.pmid: 19150955
references.citation: Pharmacogenomics. 2002 Jul;3(4):485-92
references.pmid: 12164772
references.citation: Clin Biochem. 2010 Feb;43(3):331-4
references.pmid: 19822137
references.citation: Int J Cancer. 2006 Nov 1;119(9):2030-5
references.pmid: 16804905
references.citation: Chem Biodivers. 2010 Mar;7(3):543-66
references.pmid: 20232326
references.citation: Pflugers Arch. 2004 Feb;447(5):666-76
references.pmid: 12883891
references.citation: Mutat Res. 2008 Oct 14;645(1-2):56-60
references.pmid: 18775442
references.citation: Biochem Pharmacol. 2007 Aug 1;74(3):477-87
references.pmid: 17582384
references.citation: Br J Cancer. 2004 Jul 19;91(2):344-54
references.pmid: 15213713
references.citation: Carcinogenesis. 2000 Apr;21(4):551-5
references.pmid: 10753184
references.citation: Jpn J Cancer Res. 1997 Feb;88(2):160-5
references.pmid: 9119744
references.citation: Cancer. 2008 May 1;112(9):1932-40
references.pmid: 18300238
references.citation: Clin Cancer Res. 2006 Jul 1;12(13):3928-34
references.pmid: 16818689
references.citation: Clin Pharmacol Ther. 2013 Mar;93(3):252-9
references.pmid: 23361103
references.citation: Nat Rev Drug Discov. 2005 Apr;4(4):307-20
references.pmid: 15789122
references.citation: Carcinogenesis. 1998 Feb;19(2):275-80
references.pmid: 9498276
references.citation: J Inorg Biochem. 2001 Mar;84(1-2):129-35
references.pmid: 11330471
references.citation: J Clin Oncol. 2001 Mar 15;19(6):1779-86
references.pmid: 11251009
references.citation: Clin Cancer Res. 2011 Dec 1;17(23):7470-8
references.pmid: 21998335
references.citation: Biochem Pharmacol. 2003 Apr 15;65(8):1305-16
references.pmid: 12694871
references.citation: Am J Hum Genet. 1998 May;62(5):1044-51
references.pmid: 9545395
references.citation: Cancer Res. 2002 May 1;62(9):2644-9
references.pmid: 11980662
references.citation: Cancer Biol Ther. 2011 Nov 1;12(9):780-7
references.pmid: 21892003
references.citation: Mol Pharmacol. 1993 Apr;43(4):527-33
references.pmid: 8474431
references.citation: Clin Cancer Res. 2004 Sep 1;10(17):5880-8
references.pmid: 15355920
references.citation: Pharmacogenet Genomics. 2005 Sep;15(9):647-57
references.pmid: 16041243
references.citation: Clin Cancer Res. 2007 Jun 1;13(11):3269-75
references.pmid: 17510208
references.citation: Ann N Y Acad Sci. 2000;922:188-94
references.pmid: 11193894
references.citation: J Hum Genet. 2009 Oct;54(10):572-80
references.pmid: 19696792
references.citation: J Cancer Res Clin Oncol. 2010 Nov;136(11):1681-9
references.pmid: 20165956
references.citation: Pharmacogenetics. 2002 Jun;12(4):321-30
references.pmid: 12042670
references.citation: Drug Metab Dispos. 2005 Mar;33(3):434-9
references.pmid: 15608127
references.citation: Cancer Lett. 2006 Mar 8;234(1):34-9
references.pmid: 16297532
references.citation: Oncol Rep. 2006 Jan;15(1):161-5
references.pmid: 16328050
references.citation: Drug Metab Dispos. 1998 Aug;26(8):769-74
references.pmid: 9698291
references.citation: J Clin Oncol. 2009 May 20;27(15):2457-65
references.pmid: 19364970
references.citation: Drug Metab Dispos. 2003 Jan;31(1):108-13
references.pmid: 12485959
references.citation: N Engl J Med. 2000 Jan 13;342(2):69-77
references.pmid: 10631274
references.citation: Am J Epidemiol. 2003 Apr 1;157(7):571-82
references.pmid: 12672676
references.citation: J Clin Invest. 1999 Aug;104(3):263-9
references.pmid: 10430607
references.citation: Crit Rev Clin Lab Sci. 2008;45(6):485-530
references.pmid: 19003600
references.citation: J Pharmacol Exp Ther. 1997 Apr;281(1):304-14
references.pmid: 9103511
references.citation: Genomics. 1998 Aug 1;51(3):391-400
references.pmid: 9721209
references.citation: Biochim Biophys Acta. 2006 Dec;1766(2):184-96
references.pmid: 16973289
references.citation: Clin Cancer Res. 2003 May;9(5):1611-5
references.pmid: 12738713
references.citation: Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1810-8
references.pmid: 16030121
references.citation: Int J Cancer. 2012 Nov 1;131(9):2103-16
references.pmid: 22307944
references.citation: Drug Metab Lett. 2007 Jan;1(1):23-30
references.pmid: 19356014
references.citation: Clin Cancer Res. 2006 Jun 15;12(12):3864; author reply 3864
references.pmid: 16778115
references.citation: Pharmacogenetics. 2004 Sep;14(9):595-605
references.pmid: 15475733
references.citation: Pharmacogenet Genomics. 2007 Jun;17(6):417-23
references.pmid: 17502833
references.citation: Clin Cancer Res. 1997 Sep;3(9):1653-60
references.pmid: 9815856
references.citation: Nat Genet. 1995 May;10(1):111-3
references.pmid: 7647779
references.citation: Curr Med Chem Anticancer Agents. 2004 Sep;4(5):429-34
references.pmid: 15379698
references.citation: Int J Cancer. 2002 Feb 1;97(4):451-7
references.pmid: 11802206
references.citation: Int J Clin Pharmacol Ther. 2010 Nov;48(11):729-34
references.pmid: 20979931
references.citation: Clin Pharmacol Ther. 2004 Dec;76(6):528-35
references.pmid: 15592324
references.citation: Biochemistry. 2003 May 13;42(18):5214-24
references.pmid: 12731862
references.citation: Cancer Res. 1996 Oct 1;56(19):4430-7
references.pmid: 8813137
references.citation: Int J Clin Oncol. 2008 Dec;13(6):498-503
references.pmid: 19093176
references.citation: J Gastrointest Surg. 2005 Mar;9(3):336-42
references.pmid: 15749593
references.citation: Gastroenterology. 2011 Apr;140(4):1174-81
references.pmid: 21185836
references.citation: Cancer Sci. 2007 Sep;98(9):1461-7
references.pmid: 17627617
references.citation: Cancer Chemother Pharmacol. 2010 Sep;66(4):659-67
references.pmid: 20033812
references.citation: Nan Fang Yi Ke Da Xue Xue Bao. 2012 Aug;32(8):1179-81
references.pmid: 22931617
references.citation: J Clin Oncol. 2006 Sep 1;24(25):4069-77
references.pmid: 16943524
references.citation: Clin Cancer Res. 2005 Sep 1;11(17):6100-2
references.pmid: 16144907
references.citation: Mol Genet Metab. 1998 Jul;64(3):169-72
references.pmid: 9719624
references.citation: Clin Ther. 2005 Jan;27(1):23-44
references.pmid: 15763604
references.citation: Mol Cancer Ther. 2002 Jan;1(3):227-35
references.pmid: 12467217
references.citation: Br J Clin Pharmacol. 1998 Aug;46(2):151-6
references.pmid: 9723824
references.citation: Cancer Chemother Pharmacol. 2013 Mar;71(3):733-40
references.pmid: 23299794
references.citation: J Clin Oncol. 2010 May 20;28(15):2556-64
references.pmid: 20385995
references.citation: Nat Clin Pract Urol. 2005 Aug;2(8):416-22
references.pmid: 16482653
references.citation: Cancer Chemother Pharmacol. 2005 Aug;56(2):161-72
references.pmid: 15838659
references.citation: Pharmacogenomics. 2012 Jul;13(10):1173-91
references.pmid: 22909207
references.citation: Int J Oncol. 2006 May;28(5):1303-10
references.pmid: 16596248
references.citation: Clin Transl Oncol. 2007 Sep;9(9):549-54
references.pmid: 17921101
references.citation: BMC Med Genomics. 2008 Jun 11;1:24
references.pmid: 18547414
references.citation: Cancer Res. 2002 Jan 15;62(2):459-65
references.pmid: 11809696
references.citation: Clin Cancer Res. 2009 Jul 1;15(13):4312-21
references.pmid: 19509135
references.citation: Br J Cancer. 2004 Aug 16;91(4):678-82
references.pmid: 15280927
references.citation: Med Res Rev. 2009 Nov;29(6):903-53
references.pmid: 19434693
references.citation: Arch Toxicol. 2008 Jul;82(7):415-33
references.pmid: 18491077
references.citation: Cancer Res. 1998 Aug 15;58(16):3579-85
references.pmid: 9721864
references.citation: Pharmacogenetics. 2003 Dec;13(12):741-57
references.pmid: 14646693
references.citation: J Clin Oncol. 2006 Apr 1;24(10):1603-11
references.pmid: 16575011
references.citation: Cancer Treat Rev. 2010 Nov;36(7):550-6
references.pmid: 20363564
references.citation: J Clin Oncol. 2003 Mar 15;21(6):1174-9
references.pmid: 12637487
references.citation: J Clin Oncol. 2004 Apr 15;22(8):1382-8
references.pmid: 15007088
references.citation: Clin Cancer Res. 2001 May;7(5):1343-9
references.pmid: 11350904
references.citation: Proc Natl Acad Sci U S A. 1998 Oct 27;95(22):13217-20
references.pmid: 9789068
references.citation: Nagoya J Med Sci. 2005 Jun;67(3-4):117-24
references.pmid: 17375478
references.citation: Cancer Res. 1990 Sep 15;50(18):6095-9
references.pmid: 2168289
references.citation: Oncogene. 2003 Oct 20;22(47):7296-304
references.pmid: 14576839
references.citation: Int J Clin Oncol. 2004 Aug;9(4):322-9
references.pmid: 15375710
references.citation: Clin Cancer Res. 2010 Aug 1;16(15):3832-42
references.pmid: 20562211
references.citation: Anticancer Res. 2008 Jan-Feb;28(1B):389-93
references.pmid: 18383874
references.citation: Int J Cancer. 2009 Jun 15;124(12):2905-10
references.pmid: 19296535
references.citation: DNA Cell Biol. 1995 Jan;14(1):1-6
references.pmid: 7832988
references.citation: Annu Rev Pharmacol Toxicol. 2008;48:495-535
references.pmid: 17937596
references.citation: Biochem Pharmacol. 2003 Jul 15;66(2):225-37
references.pmid: 12826265
references.citation: Cancer Chemother Pharmacol. 2010 Aug;66(3):493-500
references.pmid: 19960344
references.citation: Curr Drug Metab. 2004 Jun;5(3):211-24
references.pmid: 15180491
references.citation: Neoplasma. 2009;56(4):303-16
references.pmid: 19473056
references.citation: BMC Genomics. 2006 May 10;7:111
references.pmid: 16684361
references.citation: Pharmacogenomics. 2011 Apr;12(4):481-92
references.pmid: 21521021
references.citation: Cancer Res. 1958 Apr;18(3):318-28
references.pmid: 13523598
references.citation: Nat Rev Cancer. 2009 Jul;9(7):489-99
references.pmid: 19536109
references.citation: Pharmacogenetics. 2002 Oct;12(7):555-8
references.pmid: 12360106
references.citation: Hepatogastroenterology. 2005 Nov-Dec;52(66):1715-21
references.pmid: 16334763
references.citation: Ann Surg Oncol. 2006 Nov;13(11):1379-85
references.pmid: 17009149
references.citation: J Clin Oncol. 1997 Jan;15(1):251-60
references.pmid: 8996150
references.citation: Ann Oncol. 2011 Dec;22(12):2604-2609
references.pmid: 21415237
references.citation: Cancer Res. 2003 Sep 15;63(18):6004-7
references.pmid: 14522928
references.citation: Genet Test Mol Biomarkers. 2011 Oct;15(10):691-5
references.pmid: 21631301
references.citation: J Clin Oncol. 2003 Jan 15;21(2):241-50
references.pmid: 12525515
references.citation: J Clin Oncol. 2006 Jul 1;24(19):3061-8
references.pmid: 16809730
references.citation: Nature. 2000 Nov 16;408(6810):307-10
references.pmid: 11099028
references.citation: Int J Cancer. 2007 Feb 1;120(3):694-701
references.pmid: 17096352
references.citation: Br J Cancer. 2008 Sep 2;99(5):716-21
references.pmid: 18728661
references.citation: J Exp Ther Oncol. 2004 Apr;4(1):25-35
references.pmid: 15255290
references.citation: Cancer Res. 1998 Feb 1;58(3):468-72
references.pmid: 9458091
references.citation: Clin Cancer Res. 2003 Feb;9(2):786-91
references.pmid: 12576451
references.citation: Oncol Rep. 2007 Feb;17(2):325-8
references.pmid: 17203168
references.citation: Pharmacogenetics. 2000 Oct;10(7):629-44
references.pmid: 11037804
references.citation: Clin Cancer Res. 2003 Sep 15;9(11):4116-24
references.pmid: 14519634
references.citation: Br J Cancer. 1996 Aug;74(4):508-12
references.pmid: 8761363
references.citation: J Pharmacol Exp Ther. 2003 Oct;307(1):117-28
references.pmid: 12944498
references.citation: Oncologist. 2006 Sep;11(8):944-54
references.pmid: 16951398
references.citation: Gan To Kagaku Ryoho. 2007 Jul;34(7):1073-7
references.pmid: 17637543
references.citation: Biol Pharm Bull. 2002 Oct;25(10):1356-9
references.pmid: 12392094
references.citation: Int J Cancer. 2006 Jun 15;118(12):3084-8
references.pmid: 16425285
references.citation: Cancer Biol Ther. 2006 Aug;5(8):943-9
references.pmid: 16775422
references.citation: Ther Deliv. 2013 Mar;4(3):395-413
references.pmid: 23442083
references.citation: Proc Natl Acad Sci U S A. 1998 Jul 7;95(14):8170-4
references.pmid: 9653159
references.citation: Clin Colorectal Cancer. 2009 Mar;8(2):110-7
references.pmid: 19423505
references.citation: J Diabetes Sci Technol. 2009 Jul 01;3(4):680-4
references.pmid: 20144313
references.citation: Oncology (Williston Park). 1993 Aug;7(8):63-72; discussion 75-6
references.pmid: 8398636
references.citation: Cancer Lett. 1997 Sep 16;118(1):29-35
references.pmid: 9310257
references.citation: Nature. 1957 Mar 30;179(4561):663-6
references.pmid: 13418758
references.citation: Cancer Chemother Pharmacol. 2010 Feb;65(3):437-46
references.pmid: 19568750
references.citation: Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11592-7
references.pmid: 11553769
references.citation: Br J Cancer. 2008 Jul 22;99(2):275-82
references.pmid: 18594531
references.citation: Drug Metab Rev. 2005;37(3):565-74
references.pmid: 16257834
references.citation: Br J Clin Pharmacol. 2007 Aug;64(2):237-40
references.pmid: 17335544
references.citation: Clin Colorectal Cancer. 2011 Sep;10(3):157-64
references.pmid: 21855036
references.citation: Ann Oncol. 2005 Oct;16(10):1646-53
references.pmid: 16012177
references.citation: Oncology. 2006;70(5):366-77
references.pmid: 17179731
references.citation: Protein J. 2007 Dec;26(8):541-6
references.pmid: 17899335
references.citation: Oncogene. 2006 Jan 12;25(2):165-75
references.pmid: 16170360
references.citation: Int J Oncol. 2007 Aug;31(2):413-8
references.pmid: 17611699
references.citation: J Clin Oncol. 2010 Jul 10;28(20):3227-33
references.pmid: 20530282
references.citation: Cancer Chemother Pharmacol. 2006 Jun;57(6):835-40
references.pmid: 16187112
references.citation: Clin Cancer Res. 2004 Aug 1;10(15):5151-9
references.pmid: 15297419
references.citation: Clin Pharmacokinet. 1989 Apr;16(4):215-37
references.pmid: 2656050
references.citation: Lung Cancer. 2009 Jan;63(1):115-20
references.pmid: 18221820
references.citation: Cell Death Differ. 2009 Jul;16(7):966-75
references.pmid: 19325568
references.citation: Gan To Kagaku Ryoho. 2011 Jan;38(1):69-73
references.pmid: 21368461
references.citation: J Biol Chem. 1997 Apr 11;272(15):10004-12
references.pmid: 9092542
references.citation: Cancer Treat Rev. 2007 Feb;33(1):9-23
references.pmid: 17084534
references.citation: Clin Cancer Res. 2000 Jun;6(6):2138-45
references.pmid: 10873062